LINDSAY CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LINDSAY CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $676.37M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $607.07M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $674.08M | Oct 23, 2025 |
| FY2024 | Aug 31, 2022 | $770.74M | Oct 24, 2024 |
| FY2023 | Aug 31, 2021 | $567.65M | Oct 19, 2023 |
| FY2020 | Aug 31, 2020 | $128.41M | Oct 22, 2020 |
| FY2020 | May 31, 2020 | $123.11M | Oct 22, 2020 |
| FY2020 | Feb 29, 2020 | $113.79M | Oct 22, 2020 |
| FY2020 | Nov 30, 2019 | $109.39M | Oct 22, 2020 |
| FY2020 | Aug 31, 2019 | $101.89M | Oct 22, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $659.07M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $584.26M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $661.91M | Oct 23, 2025 |
| FY2024 | Aug 31, 2022 | $760.26M | Oct 24, 2024 |
| FY2022 | Aug 31, 2021 | $551.28M | Oct 20, 2022 |
| FY2021 | Aug 31, 2020 | $463.21M | Oct 21, 2021 |
| FY2020 | Aug 31, 2019 | $436.32M | Oct 22, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $210.78M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $191.06M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $213.02M | Oct 23, 2025 |
| FY2024 | Aug 31, 2022 | $199.18M | Oct 24, 2024 |
| FY2023 | Aug 31, 2021 | $150.21M | Oct 19, 2023 |
| FY2022 | Aug 31, 2020 | $152.54M | Oct 20, 2022 |
| FY2021 | Aug 31, 2019 | $114.61M | Oct 21, 2021 |
| FY2020 | Aug 31, 2018 | $151.46M | Oct 22, 2020 |
| FY2019 | Aug 31, 2017 | $145.01M | Oct 31, 2019 |
| FY2018 | Aug 31, 2016 | $148.61M | Oct 24, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $74.05M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $66.26M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $72.38M | Oct 23, 2025 |
| FY2024 | Aug 31, 2022 | $65.47M | Oct 24, 2024 |
| FY2023 | Aug 31, 2021 | $42.57M | Oct 19, 2023 |
| FY2020 | Aug 31, 2020 | $14.67M | Oct 22, 2020 |
| FY2020 | May 31, 2020 | $10.09M | Oct 22, 2020 |
| FY2020 | Feb 29, 2020 | $5.52M | Oct 22, 2020 |
| FY2020 | Nov 30, 2019 | $8.35M | Oct 22, 2020 |
| FY2020 | Aug 31, 2019 | $1.50M | Oct 22, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $88.12M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $76.61M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $102.18M | Oct 23, 2025 |
| FY2024 | Aug 31, 2022 | $94.64M | Oct 24, 2024 |
| FY2023 | Aug 31, 2021 | $54.11M | Oct 19, 2023 |
| FY2022 | Aug 31, 2020 | $54.20M | Oct 20, 2022 |
| FY2021 | Aug 31, 2019 | $6.12M | Oct 21, 2021 |
| FY2020 | Aug 31, 2018 | $39.01M | Oct 22, 2020 |
| FY2019 | Aug 31, 2017 | $40.65M | Oct 31, 2019 |
| FY2018 | Aug 31, 2016 | $34.38M | Oct 24, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $17.93M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $17.12M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $18.22M | Oct 23, 2025 |
| FY2024 | Aug 31, 2022 | $15.15M | Oct 24, 2024 |
| FY2023 | Aug 31, 2021 | $13.36M | Oct 19, 2023 |
| FY2022 | Aug 31, 2020 | $13.95M | Oct 20, 2022 |
| FY2021 | Aug 31, 2019 | $13.94M | Oct 21, 2021 |
| FY2020 | Aug 31, 2018 | $16.03M | Oct 22, 2020 |
| FY2019 | Aug 31, 2017 | $17.15M | Oct 31, 2019 |
| FY2018 | Aug 31, 2016 | $15.85M | Oct 24, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $132.91M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $95.76M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $119.71M | Oct 23, 2025 |
| FY2024 | Aug 31, 2022 | $3.05M | Oct 24, 2024 |
| FY2023 | Aug 31, 2021 | $43.97M | Oct 19, 2023 |
| FY2022 | Aug 31, 2020 | $46.03M | Oct 20, 2022 |
| FY2021 | Aug 31, 2019 | $3.80M | Oct 21, 2021 |
| FY2020 | Aug 31, 2018 | $33.93M | Oct 22, 2020 |
| FY2019 | Aug 31, 2017 | $39.45M | Oct 31, 2019 |
| FY2018 | Aug 31, 2016 | $33.13M | Oct 24, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $42.50M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $28.98M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $18.78M | Oct 23, 2025 |
| FY2024 | Aug 31, 2022 | $15.60M | Oct 24, 2024 |
| FY2023 | Aug 31, 2021 | $26.51M | Oct 19, 2023 |
| FY2022 | Aug 31, 2020 | $21.45M | Oct 20, 2022 |
| FY2021 | Aug 31, 2019 | $23.21M | Oct 21, 2021 |
| FY2020 | Aug 31, 2018 | $11.05M | Oct 22, 2020 |
| FY2019 | Aug 31, 2017 | $8.86M | Oct 31, 2019 |
| FY2018 | Aug 31, 2016 | $11.50M | Oct 24, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $840.84M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $760.23M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $745.66M | Oct 24, 2024 |
| FY2023 | Aug 31, 2022 | $710.65M | Oct 19, 2023 |
| FY2022 | Aug 31, 2021 | $637.19M | Oct 20, 2022 |
| FY2021 | Aug 31, 2020 | $570.53M | Oct 21, 2021 |
| FY2020 | Aug 31, 2019 | $500.31M | Oct 22, 2020 |
| FY2020 | Aug 31, 2018 | $499.82M | Oct 22, 2020 |
| FY2019 | Aug 31, 2017 | $506.03M | Oct 31, 2019 |
| FY2018 | Aug 31, 2016 | $487.52M | Oct 24, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $307.99M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $279.34M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $290.01M | Oct 24, 2024 |
| FY2023 | Aug 31, 2022 | $317.30M | Oct 19, 2023 |
| FY2022 | Aug 31, 2021 | $298.74M | Oct 20, 2022 |
| FY2021 | Aug 31, 2020 | $272.01M | Oct 21, 2021 |
| FY2020 | Aug 31, 2019 | $232.11M | Oct 22, 2020 |
| FY2019 | Aug 31, 2018 | $222.95M | Oct 31, 2019 |
| FY2018 | Aug 31, 2017 | $235.98M | Oct 24, 2018 |
| FY2017 | Aug 31, 2016 | $235.95M | Oct 13, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $532.85M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $480.89M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $455.65M | Oct 23, 2025 |
| FY2024 | Aug 31, 2022 | $393.36M | Oct 23, 2025 |
| FY2024 | Aug 31, 2021 | $338.45M | Oct 24, 2024 |
| FY2023 | Aug 31, 2020 | $298.52M | Oct 19, 2023 |
| FY2022 | Aug 31, 2019 | $268.21M | Oct 20, 2022 |
| FY2021 | Aug 31, 2018 | $276.87M | Oct 21, 2021 |
| FY2020 | Aug 31, 2017 | $270.06M | Oct 22, 2020 |
| FY2019 | Aug 31, 2016 | $251.57M | Oct 31, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $84.46M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $84.19M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $83.12M | Oct 23, 2025 |
| FY2024 | Aug 31, 2022 | $67.13M | Oct 24, 2024 |
| FY2023 | Aug 31, 2021 | $67.97M | Oct 19, 2023 |
| FY2022 | Aug 31, 2020 | $68.00M | Oct 20, 2022 |
| FY2021 | Aug 31, 2019 | $64.39M | Oct 21, 2021 |
| FY2020 | Aug 31, 2018 | $64.67M | Oct 22, 2020 |
| FY2019 | Aug 31, 2017 | $77.13M | Oct 31, 2019 |
| FY2018 | Aug 31, 2016 | $76.80M | Oct 24, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $745.40M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $687.09M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $636.30M | Oct 24, 2024 |
| FY2023 | Aug 31, 2022 | $579.00M | Oct 19, 2023 |
| FY2022 | Aug 31, 2021 | $528.13M | Oct 20, 2022 |
| FY2021 | Aug 31, 2020 | $499.72M | Oct 21, 2021 |
| FY2020 | Aug 31, 2019 | $474.74M | Oct 22, 2020 |
| FY2019 | Aug 31, 2018 | $484.89M | Oct 31, 2019 |
| FY2018 | Aug 31, 2017 | $477.62M | Oct 24, 2018 |
| FY2017 | Aug 31, 2016 | $466.93M | Oct 13, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $250.58M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $190.88M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $160.76M | Oct 24, 2024 |
| FY2023 | Aug 31, 2022 | $105.05M | Oct 19, 2023 |
| FY2022 | Aug 31, 2021 | $127.11M | Oct 20, 2022 |
| FY2021 | Aug 31, 2020 | $121.40M | Oct 21, 2021 |
| FY2020 | Aug 31, 2019 | $127.20M | Oct 22, 2020 |
| FY2019 | Aug 31, 2018 | $160.79M | Oct 31, 2019 |
| FY2018 | Aug 31, 2017 | $121.62M | Oct 24, 2018 |
| FY2018 | Aug 31, 2016 | $101.25M | Oct 24, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | $115.26M | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | $115.49M | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | $115.71M | Oct 24, 2024 |
| FY2023 | Aug 31, 2022 | $115.93M | Oct 19, 2023 |
| FY2022 | Aug 31, 2021 | $116.15M | Oct 20, 2022 |
| FY2021 | Aug 31, 2020 | $116.34M | Oct 21, 2021 |
| FY2020 | Aug 31, 2019 | $116.57M | Oct 22, 2020 |
| FY2019 | Aug 31, 2018 | $116.78M | Oct 31, 2019 |
| FY2018 | Aug 31, 2017 | $116.98M | Oct 24, 2018 |
| FY2017 | Aug 31, 2016 | $117.17M | Oct 13, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | 6 | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | 6 | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | 6 | Oct 23, 2025 |
| FY2024 | Aug 31, 2022 | 5 | Oct 24, 2024 |
| FY2023 | Aug 31, 2021 | 3 | Oct 19, 2023 |
| FY2022 | Aug 31, 2020 | 3 | Oct 20, 2022 |
| FY2021 | Aug 31, 2019 | 0 | Oct 21, 2021 |
| FY2020 | Aug 31, 2018 | 1 | Oct 22, 2020 |
| FY2019 | Aug 31, 2017 | 2 | Oct 31, 2019 |
| FY2018 | Aug 31, 2016 | 1 | Oct 24, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2025 | 6 | Oct 23, 2025 |
| FY2024 | Aug 31, 2024 | 6 | Oct 23, 2025 |
| FY2024 | Aug 31, 2023 | 6 | Oct 23, 2025 |
| FY2024 | Aug 31, 2022 | 5 | Oct 24, 2024 |
| FY2023 | Aug 31, 2021 | 3 | Oct 19, 2023 |
| FY2020 | Aug 31, 2020 | 1 | Oct 22, 2020 |
| FY2020 | May 31, 2020 | 0 | Oct 22, 2020 |
| FY2020 | Feb 29, 2020 | 0 | Oct 22, 2020 |
| FY2020 | Nov 30, 2019 | 0 | Oct 22, 2020 |
| FY2020 | Aug 31, 2019 | 0 | Oct 22, 2020 |